Publications by authors named "Michael S. Gordon"

Claim this Profile
P
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
Gayle S Jameson, S Danielle LeGrand, Michael S Gordon, Denise J Roe, Betsy C Wertheim

Redox Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
Rebecca Porter, Bruno Bockorny, Bradley R Corr, Daruka Mahadevan, Breelyn A Wilky, Michael S Gordon

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Operations Backed by Best Practices in American Problem-Solving Courts?
Lindsay R Smith, Fanni Faragó, Thomas Blue, James C Witte, Michael S Gordon

J Subst Use· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing real-time assessments of substance use cravings, triggers, and mood: a feasibility study with justice-involved populations.
Ginnie Sawyer-Morris, McKenna Halverson, Kelly M Maher, Steven B Carswell, Michael S Gordon

Health Justice· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Prevalence of Burnout in Psychiatric Doctors Before and After the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.
Kathryn L Johnson, Michael S Gordon, Hannah G Gordon

J Clin Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine.
Thomas R Blue, Michael S Gordon, Frank J Vocci, Marc J Fishman, Shannon Gwin Mitchell

J Addict Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research themes and key data points for child and adolescent emergency department mental health presentations: A national Delphi study.
Marietta R John-White, Edmund Proper, Frank Muscara, Franz E Babl, Vicki A Anderson, Michael S Gordon

Acad Emerg Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Breelyn A Wilky, Gary K Schwartz, Michael S Gordon, Anthony B El-Khoueiry, Andrea J Bullock

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman, Michael S Gordon

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals.
Michael S Gordon, Thomas R Blue, Frank J Vocci, Shannon G Mitchell, Kevin R Wenzel

Drug Alcohol Depend Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Alice N Weaver, Wade T Iams, Jong Chul Park, Monica Mita, Udo Holtick, Michael S Gordon

Mol Carcinog· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.
Tae Won Kim, Philippe L Bedard, Patricia LoRusso, Michael S Gordon, Johanna Bendell

JAMA Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viewing Then Doing?: Problem-Solving Court Coordinators' Perceptions of Medications for Opioid Use Disorders from a Nationally Representative Survey in the United States.
Lindsay R Smith, Fanni Faragó, Thomas Blue, James C Witte, Michael S Gordon

Subst Use Misuse· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic Procedures: Adapting Problem-Solving Court (PSC) Operations and Treatment Protocols During COVID-19.
Lindsay R Smith, Fanni Faragó, James C Witte, Thomas Blue, Michael S Gordon

J Drug Issues· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
James Larkin, Mototsugu Oya, Marcella Martignoni, Fiona Thistlethwaite, Paul Nathan, Michael S Gordon

Oncologist· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Antonio Jimeno, Joaquina Baranda, Wade T Iams, Jong Chul Park, Monica Mita, Michael S Gordon

Invest New Drugs· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Emergency management of Agitation in Children and Young people: protocol for a randomised controlled trial of intraMuscular medication (PEAChY-M).
Elyssia M Bourke, Meredith L Borland, Amit Kochar, Shane George, Deborah Shellshear, Michael Solomon Gordon

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological emergency management of agitation in children and young people: protocol for a randomised controlled trial of oral medication (PEAChY-O).
Elyssia M Bourke, Meredith L Borland, Amit Kochar, Shane George, Deborah Shellshear, Michael Solomon Gordon

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Kevin Drenner, Gargi D Basu, Laurie J Goodman, Audrey A Ozols, Janine R LoBello, Michael S Gordon

Oncotarget· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.
K Gary Barnette, Michael S Gordon, Domingo Rodriguez, T Gary Bird, Alan Skolnick

NEJM Evid· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability, safety and tolerability of antidepressant repetitive transcranial magnetic stimulation for adolescents: A mixed-methods investigation.
Emily Jean Wallman, Rebecca Anne Segrave, Michael Solomon Gordon, Maxwell James Oliver Barnett Fraser, Chris Pavlou

J Affect Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
Kevin L Winthrop, Alan W Skolnick, Adnan M Rafiq, Scott H Beegle, Julian Suszanski, Michael S Gordon

Open Forum Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and use of a checklist for the implementation of medication for opioid use disorder in jails.
Ariel Ludwig, Laura B Monico, Thomas Blue, Michael S Gordon, Robert P Schwartz

Implement Res Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing Care App for Probationers and Parolees with Substance use Disorders.
Steven B Carswell, Michael S Gordon, Jan Gryczynski, Faye S Taxman, Mary Schadegg

J Drug Educ· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Michael S Gordon, Geoffrey I Shapiro, John Sarantopoulos, Dejan Juric, Brian Lu

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis